Investee Company: MingMed has completed raising nearly $50 million in Series A+ round - Oceanpine Capital
Summary
, the company announced on Monday.New investors who participated in the said round are healthcare industry-focused Jifeng Ventures and Yifeng Capital, Oceanpine Capital, as well as Nasdaq-listed Chinese cosmetics e-commerce platform YSG. Returning investors Gaorong Capital, JCP Capital, Flower City Ventures re-upped in it.MingMed has raised about $110 million in the last six months. It secured as much as $60 million in its Series A round in March this year from investors including Lightspeed China Partners, Gaorong Capital, state-backed Hengqin Financial Investment, Guangzhou-based Flower City Ventures and JCP Capital.MingMed, headquartered in Guangzhou, was established in 2019. It has launched products for specialized areas like ophthalmology, small molecule immuno oncology, gene editing-based immunotherapy, medical aesthetics besides pet medicine.